Greenwood Capital Associates LLC Raises Position in Colgate-Palmolive (CL)
Greenwood Capital Associates LLC increased its stake in shares of Colgate-Palmolive (NYSE:CL) by 8.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,663 shares of the company’s stock after purchasing an additional 1,879 shares during the period. Greenwood Capital Associates LLC’s holdings in Colgate-Palmolive were worth $1,861,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. raised its position in shares of Colgate-Palmolive by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after purchasing an additional 1,621,392 shares during the last quarter. Renaissance Technologies LLC raised its holdings in Colgate-Palmolive by 42.4% in the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after acquiring an additional 2,903,800 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in Colgate-Palmolive by 25.3% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock valued at $508,111,000 after acquiring an additional 1,385,946 shares during the last quarter. First Eagle Investment Management LLC raised its holdings in Colgate-Palmolive by 35.8% in the 3rd quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock valued at $483,837,000 after acquiring an additional 1,750,417 shares during the last quarter. Finally, APG Asset Management N.V. raised its holdings in Colgate-Palmolive by 33.2% in the 4th quarter. APG Asset Management N.V. now owns 5,421,184 shares of the company’s stock valued at $340,630,000 after acquiring an additional 1,350,400 shares during the last quarter. Hedge funds and other institutional investors own 72.85% of the company’s stock.
Shares of Colgate-Palmolive (CL) opened at $69.76 on Monday. The company has a current ratio of 0.47, a quick ratio of 0.34 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a twelve month low of $66.47 and a twelve month high of $77.91. The company has a market capitalization of $61,256.62, a price-to-earnings ratio of 30.60, a PEG ratio of 2.58 and a beta of 0.75.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be given a dividend of $0.40 per share. The ex-dividend date is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a yield of 2.29%. Colgate-Palmolive’s dividend payout ratio (DPR) is 70.18%.
In related news, Director Ellen M. Hancock sold 4,676 shares of the company’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $74.12, for a total transaction of $346,585.12. Following the completion of the sale, the director now directly owns 208,063 shares of the company’s stock, valued at approximately $15,421,629.56. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Henning I. Jakobsen sold 36,215 shares of the company’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $71.22, for a total transaction of $2,579,232.30. Following the sale, the vice president now directly owns 70,783 shares of the company’s stock, valued at $5,041,165.26. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 327,451 shares of company stock valued at $23,534,707. 1.02% of the stock is owned by corporate insiders.
Several research analysts have weighed in on CL shares. BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Morgan Stanley cut their price target on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a report on Tuesday, October 31st. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday, October 17th. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Finally, Jefferies Group cut their price target on Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a report on Monday, October 30th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $77.71.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.